Literature DB >> 25957267

The cell surface receptor Slamf6 modulates innate immune responses during Citrobacter rodentium-induced colitis.

Boaz van Driel1, Guoxing Wang1, Gongxian Liao1, Peter J Halibozek1, Marton Keszei1, Michael S O'Keeffe1, Atul K Bhan2, Ninghai Wang1, Cox Terhorst3.   

Abstract

The homophilic cell surface receptors CD150 (Slamf1) and CD352 (Slamf6) are known to modulate adaptive immune responses. Although the Th17 response was enhanced in Slamf6(-/-) C57BL/6 mice upon oral infection with Citrobacter rodentium, the pathologic consequences are indistinguishable from an infection of wild-type C57BL/6 mice. Using a reporter-based binding assay, we show that Slamf6 can engage structures on the outer cell membrane of several Gram(-) bacteria. Therefore, we examined whether Slamf6, like Slamf1, is also involved in innate responses to bacteria and regulates peripheral inflammation by assessing the outcome of C. rodentium infections in Rag(-/-) mice. Surprisingly, the pathology and immune responses in the lamina propria of C. rodentium-infected Slamf6(-/-) Rag(-/-) mice were markedly reduced as compared with those of Rag(-/-) mice. Infiltration of inflammatory phagocytes into the lamina propria was consistently lower in Slamf6(-/-) Rag(-/-) mice than in Rag(-/-) animals. Concomitant with the reduced systemic translocation of the bacteria was an enhanced production of IL-22, suggesting that Slamf6 suppresses a mucosal protective program. Furthermore, administering a mAb (330) that inhibits bacterial interactions with Slamf6 to Rag(-/-) mice ameliorated the infection compared with a control antibody. We conclude that Slamf6-mediated interactions of colonic innate immune cells with specific Gram(-) bacteria reduce mucosal protection and enhance inflammation, contributing to lethal colitis that is caused by C. rodentium infections in Rag(-/-) mice. © The Japanese Society for Immunology. 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Citrobacter rodentium; IL-22; Slamf6; innate; mucosal immunology

Mesh:

Substances:

Year:  2015        PMID: 25957267      PMCID: PMC4560040          DOI: 10.1093/intimm/dxv029

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  34 in total

1.  CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance.

Authors:  Jan Hendrik Niess; Stephan Brand; Xiubin Gu; Limor Landsman; Steffen Jung; Beth A McCormick; Jatin M Vyas; Marianne Boes; Hidde L Ploegh; James G Fox; Dan R Littman; Hans-Christian Reinecker
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

2.  CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium.

Authors:  Lynn Bry; Manfred Brigl; Michael B Brenner
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48.

Authors:  R Malaviya; Z Gao; K Thankavel; P A van der Merwe; S N Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

4.  SLAM (CDw150) is a cellular receptor for measles virus.

Authors:  H Tatsuo; N Ono; K Tanaka; Y Yanagi
Journal:  Nature       Date:  2000-08-24       Impact factor: 49.962

5.  Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection.

Authors:  Bruce A Vallance; Wanyin Deng; Leigh A Knodler; B Brett Finlay
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

6.  Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium.

Authors:  Cameron P Simmons; Simon Clare; Marjan Ghaem-Maghami; Tania K Uren; Joanna Rankin; Allan Huett; Rob Goldin; David J Lewis; Thomas T MacDonald; Richard A Strugnell; Gad Frankel; Gordon Dougan
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

Authors:  F Powrie; M W Leach; S Mauze; L B Caddle; R L Coffman
Journal:  Int Immunol       Date:  1993-11       Impact factor: 4.823

Review 8.  The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease.

Authors:  Pablo Engel; Michael J Eck; Cox Terhorst
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

9.  CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22.

Authors:  Randy S Longman; Gretchen E Diehl; Daniel A Victorio; Jun R Huh; Carolina Galan; Emily R Miraldi; Arun Swaminath; Richard Bonneau; Ellen J Scherl; Dan R Littman
Journal:  J Exp Med       Date:  2014-07-14       Impact factor: 14.307

Review 10.  Citrobacter rodentium: infection, inflammation and the microbiota.

Authors:  James W Collins; Kristie M Keeney; Valerie F Crepin; Vijay A K Rathinam; Katherine A Fitzgerald; B Brett Finlay; Gad Frankel
Journal:  Nat Rev Microbiol       Date:  2014-08-04       Impact factor: 60.633

View more
  6 in total

1.  Identification of hub genes associated with the pathogenesis of diffuse large B-cell lymphoma subtype one characterized by host response via integrated bioinformatic analyses.

Authors:  Lingna Zhou; Liya Ding; Yuqi Gong; Jing Zhao; Gong Xin; Ren Zhou; Wei Zhang
Journal:  PeerJ       Date:  2020-11-20       Impact factor: 2.984

Review 2.  SLAMF6 in health and disease: Implications for therapeutic targeting.

Authors:  Burcu Yigit; Ninghai Wang; Roland W Herzog; Cox Terhorst
Journal:  Clin Immunol       Date:  2018-10-23       Impact factor: 3.969

3.  The MHC Class II Immunopeptidome of Lymph Nodes in Health and in Chemically Induced Colitis.

Authors:  Tim Fugmann; Adriana Sofron; Danilo Ritz; Franziska Bootz; Dario Neri
Journal:  J Immunol       Date:  2016-12-23       Impact factor: 5.422

4.  SLAMF6/Ly108 promotes the development of hepatocellular carcinoma via facilitating macrophage M2 polarization.

Authors:  Qi Meng; Xiuyun Duan; Qingchao Yang; Dewen Xue; Zihao Liu; Yuanyuan Li; Qingyan Jin; Fang Guo; Shijie Jia; Zhaofeng Wang; Wenjiang Yan; Xu Chang; Peng Sun
Journal:  Oncol Lett       Date:  2022-01-17       Impact factor: 2.967

Review 5.  Responses to Microbial Challenges by SLAMF Receptors.

Authors:  Boaz Job van Driel; Gongxian Liao; Pablo Engel; Cox Terhorst
Journal:  Front Immunol       Date:  2016-01-20       Impact factor: 7.561

Review 6.  SLAM Family Receptor Signaling in Viral Infections: HIV and Beyond.

Authors:  Patrick O'Connell; Andrea Amalfitano; Yasser A Aldhamen
Journal:  Vaccines (Basel)       Date:  2019-11-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.